Executive Moves Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board. April 12, 2019